SurModics Inc (SRDX) - Product Pipeline Analysis, 2017 Update

GlobalData
43 Pages - GLDATA62876
$750.00

Summary

SurModics Inc (SurModics) is a provider of drug delivery and in vitro diagnostic technologies. The company offers wide range of advanced technologies that includes drug delivery technologies and surface modification coating technologies. Its technologies are employed in the development of new medical devices, biomedical products and in the enhancement of existing products and devices. SurModics commercializes its technologies through licensing and royalty arrangements with medical device manufacturers. SurModics sells components for in vitro diagnostic test kits and microarrays; and manufactures and distributes surface coatings to the diagnostic and biomedical research markets. The company has a wide distribution network across the world. SurModics is headquartered in Minnesota, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company SurModics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

'

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
SurModics Inc Company Overview 5
SurModics Inc Company Snapshot 5
SurModics Inc Pipeline Products and Ongoing Clinical Trials Overview 5
SurModics Inc – Pipeline Analysis Overview 8
Business Description 8
SurModics Inc - Key Facts 9
SurModics Inc - Major Products and Services 10
SurModics Inc Pipeline Products by Development Stage 11
SurModics Inc Ongoing Clinical Trials by Trial Status 13
SurModics Inc Pipeline Products Overview 15
0.018” OTW Dual Lumen PTA Catheter 15
0.018” OTW Dual Lumen PTA Catheter Product Overview 15
0.018” RX Dual Lumen PTA Catheter 16
0.018” RX Dual Lumen PTA Catheter Product Overview 16
0.035” Large Diameter OTW PTA Catheter 17
0.035” Large Diameter OTW PTA Catheter Product Overview 17
0.035” Next Generation Workhorse PTA Catheter 18
0.035” Next Generation Workhorse PTA Catheter Product Overview 18
I-vation Sustained Drug Delivery System - TA 19
I-vation Sustained Drug Delivery System - TA Product Overview 19
Neuraxo Implant 20
Neuraxo Implant Product Overview 20
Renal Stent System 21
Renal Stent System Product Overview 21
SurVeil Drug Coated Balloon - Arterio Venous (AV) Fistulas 22
SurVeil Drug Coated Balloon - Arterio Venous (AV) Fistulas Product Overview 22
SurVeil Drug Coated Balloon - Below The Knee (BTK) 23
SurVeil Drug Coated Balloon - Below The Knee (BTK) Product Overview 23
SurVeil Drug Coated Balloon - Coronary 24
SurVeil Drug Coated Balloon - Coronary Product Overview 24
SurVeil Drug Coated Balloon - SFA 25
SurVeil Drug Coated Balloon - SFA Product Overview 25
SurVeil Drug Coated Balloon - SFA Clinical Trial 26
SurModics Inc - Key Competitors 27
SurModics Inc - Key Employees 28
SurModics Inc - Key Employee Biographies 29
SurModics Inc - Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
SurModics Inc, Recent Developments 31
Feb 02, 2017: Surmodics Reports First Quarter Fiscal 2017 Results 31
Nov 16, 2016: Surmodics Reports Fourth Quarter Fiscal 2016 Results 32
Oct 31, 2016: Surmodics Announces Launch of Serene Single-Coat (SC) Solutions Offering Unmatched Lubricity and Durability to a Broader Range of Device Applications 33
Aug 01, 2016: Surmodics IVD Launches Breakthrough StabilBlock Immunoassay Stabilizer 33
Jul 28, 2016: Surmodics Reports Third Quarter Fiscal 2016 Results 34
May 02, 2016: SurModics Reports Second Quarter Fiscal 2016 Results 35
Apr 06, 2016: SurModics Announces First Patient Enrolled in IDE Study of SurVeil Drug-Coated Balloon 36
Jan 28, 2016: SurModics Reports First Quarter Fiscal 2016 Results 37
Jan 08, 2016: SurModics Provides Updated 2016 Guidance 38
Dec 22, 2015: SurModics Announces Device Veteran Shawn McCormick Joins Board of Directors 38
Appendix 40
Methodology 40
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
SurModics Inc Pipeline Products and Ongoing Clinical Trials Overview 5
SurModics Inc Pipeline Products by Equipment Type 6
SurModics Inc Pipeline Products by Indication 7
SurModics Inc Ongoing Clinical Trials by Trial Status 7
SurModics Inc, Key Facts 9
SurModics Inc, Major Products and Services 10
SurModics Inc Number of Pipeline Products by Development Stage 11
SurModics Inc Pipeline Products Summary by Development Stage 12
SurModics Inc Ongoing Clinical Trials by Trial Status 13
SurModics Inc Ongoing Clinical Trials Summary 14
0.018” OTW Dual Lumen PTA Catheter - Product Status 15
0.018” OTW Dual Lumen PTA Catheter - Product Description 15
0.018” RX Dual Lumen PTA Catheter - Product Status 16
0.018” RX Dual Lumen PTA Catheter - Product Description 16
0.035” Large Diameter OTW PTA Catheter - Product Status 17
0.035” Large Diameter OTW PTA Catheter - Product Description 17
0.035” Next Generation Workhorse PTA Catheter - Product Status 18
0.035” Next Generation Workhorse PTA Catheter - Product Description 18
I-vation Sustained Drug Delivery System - TA - Product Status 19
I-vation Sustained Drug Delivery System - TA - Product Description 19
Neuraxo Implant - Product Status 20
Neuraxo Implant - Product Description 20
Renal Stent System - Product Status 21
Renal Stent System - Product Description 21
SurVeil Drug Coated Balloon - Arterio Venous (AV) Fistulas - Product Status 22
SurVeil Drug Coated Balloon - Arterio Venous (AV) Fistulas - Product Description 22
SurVeil Drug Coated Balloon - Below The Knee (BTK) - Product Status 23
SurVeil Drug Coated Balloon - Below The Knee (BTK) - Product Description 23
SurVeil Drug Coated Balloon - Coronary - Product Status 24
SurVeil Drug Coated Balloon - Coronary - Product Description 24
SurVeil Drug Coated Balloon - SFA - Product Status 25
SurVeil Drug Coated Balloon - SFA - Product Description 25
SurVeil Drug Coated Balloon - SFA - A Prospective, Multi-center, Single-arm Trial to Assess the Safety and Feasibility of the SurModics Drug Coated Balloon in the Treatment of Subjects with De Novo Lesions of the Femoropopliteal Artery 26
SurModics Inc, Key Employees 28
SurModics Inc, Key Employee Biographies 29
SurModics Inc, Subsidiaries 30
Glossary 41

List of Figures
SurModics Inc Pipeline Products by Equipment Type 6
SurModics Inc Pipeline Products by Development Stage 11
SurModics Inc Ongoing Clinical Trials by Trial Status 13

$750.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838